(Q43251930)

17 November 2017

0 references

Zinc treatment for symptomatic Wilson disease: moving forward by looking back (English)

1 reference

17 November 2017

1 reference

Michael Schilsky

1

1 reference

PubMed ID

19877301

17 November 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

50

1 reference

17 November 2017

5

1 reference

17 November 2017

1341-1343

1 reference

Diagnosis and treatment of Wilson disease: an update

17 November 2017

1 reference

Function and regulation of human copper-transporting ATPases

21 January 2018

1 reference

Hepatocellular copper toxicity and its attenuation by zinc

21 January 2018

1 reference

Introduction to tumor immunotherapy

21 January 2018

1 reference

Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years

21 January 2018

1 reference

Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy

21 January 2018

1 reference

Treatment of Wilson's disease with zinc: XV long-term follow-up studies

21 January 2018

1 reference

Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients

21 January 2018

1 reference

Prognosis of Wilsonian chronic active hepatitis

21 January 2018

1 reference

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease

21 January 2018

1 reference

Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment.

21 January 2018

1 reference

21 January 2018

1 reference

Prevention of Wilson's Disease in Asymptomatic Patients

21 January 2018

1 reference

7 January 2021

Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin

1 reference

7 January 2021

Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens

1 reference

7 January 2021

Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration)

1 reference

7 January 2021

Treatment of Wilson's disease: in D-penicillamine we trust--what about zinc?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23355

1 reference

17 November 2017

1 reference

PubMed ID

19877301